The findings from the Wilson, Ward and Carragher labs represent a scientific feat as well as progress toward an HIV vaccine.
A team led in part by the Burton lab has pointed to monoclonal antibodies as a potential tool to hold the virus in check.
“NIH has recognized what we have known all along—that George is a leader in addiction research with a vision for what needs to be done,” says TSRI President and CEO Michael Marletta.